Skip to main content
. 2009 Jul 13;3(5):241–251. doi: 10.1111/j.1750-2659.2009.00095.x

Figure 5.

Figure 5

 Antiviral susceptibility testing using ELVIRA Flu A‐luc and ELVIRA Flu B‐Rluc cells Bafilomycin (0·78–30 nm) and amantadine (4 –62 μm) were added to ELVIRA® Flu A‐luc cells and incubated at 37°C for 30 minutes and then the cells were infected with influenza A or B virus. Luciferase activity was measured after 24 hours. Data expressed as per cent no‐drug control. (A) Bafilomycin inhibition curve of influenza A virus (A/MHIA0009) ELVIRA® Flu A‐luc cells. (B) Amantadine inhibition curve of influenza A virus (A/MHIA0009) on ELVIRA® Flu A‐luc cells. (C) Bafilomycin inhibition of influenza B virus (B/Malaysia/2506/04) on ELVIRA® Flu B‐Rluc cells. (D) Amantadine inhibition of influenza B virus (B/Malaysia/2506/04) on ELVIRA® Flu B‐Rluc cells.